Market Research Logo

North America Blood Plasma Market Forecast 2018-2026

North America Blood Plasma Market Forecast 2018-2026

KEY FINDINGS

Increasing number of people suffering from chronic diseases and the rising prevalence of blood cancers can be majorly attributed to the North American blood plasma market’s growth. Between the projected years of 2018-2026, the North American blood plasma market is expected to progress with a CAGR of 6.77%.

MARKET INSIGHTS

Blood plasma components have the potential to treat various chronic diseases such as haemorrhages, leukaemia and haemophilia, and play a vital role in R&D conducted by academic institutions. In fact, Hospitals, clinics and research institutions are the major end-user industries of this market. The North American blood plasma market is also classified on the basis of blood types and applications. Although the US market presently leads this region, it is the Canada blood plasma market that is expected to rise with the fastest CAGR over the projected years of 2018-2026.

COMPETITIVE INSIGHTS

Few of the known market companies that are actively involved in this market include Octopharma Ag, Biotest Ag, General Electric Co, Cerus Corp, Baxter International Inc, Adma Biologics Inc, Grifols International S.A and Shire Plc.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Provision Of Better Healthcare Infrastructure In Developed Countries
3.2.2. Immunoglobulin Blood Type Holds The Largest Market Share By 2026
3.2.3. Transplantation Is Anticipated To Be The Fastest Growing Application In Blood Plasma
4. Market Determinants
4.1. Market Drivers
4.1.1. Exploitation Of New Therapeutic Indications
4.1.2. Rising Prevalence Of Alpha-1 Antitrypsin Deficiency (Aatd)
4.1.3. Increase In Patient Pool For Hemophilia Treatment
4.2. Restraints
4.2.1. Rising Use Of Recombinant Plasma Products In Therapeutic Treatments
4.2.2. High Costs Of Blood Plasma Treatments
4.2.3. Adverse Reactions Associated With Post-transfusion
4.3. Opportunities
4.3.1. Rising Incidence Of Hemophilia
4.3.2. Growing Public Awareness
4.3.3. New Product Opportunities
4.4. Challenges
4.4.1. Spread Of Pathogenic Contaminants
4.4.2. High Regulations In The Market
5. Market By Mode Of Delivery
5.1. Infusion Solutions
5.2. Gels
5.3. Sprays
5.4. Biomedical Sealants
6. Market Segmentation
6.1. Market By Blood Type 2018-2026
6.1.1. Immunoglobulin
6.1.1.1. Intravenous Immunoglobulin
6.1.1.2. Subcutaneous Immunoglobulin
6.1.1.3. Other Immunoglobulin Type
6.1.2. Albumin
6.1.3. Hyperimmunes
6.1.4. Coagulation Factor Concentrates
6.1.5. Other Plasma Fractionation Products
6.2. Market By Application 2018-2026
6.2.1. Immunology
6.2.2. Oncology
6.2.3. Pulmonology
6.2.4. Rheumatology
6.2.5. Transplantation
6.2.6. Neurology
6.2.7. Hematology
6.2.8. Other Applications
6.3. Market By End User 2018-2026
6.3.1. Hospitals And Clinics
6.3.2. Research Laboratories
6.3.3. Academic Institutions
7. Key Analytics
7.1. Porter’s Five Force Analysis
7.1.1. Threat Of New Entrants
7.1.2. Threat Of Substitutes
7.1.3. Bargaining Power Of Buyers
7.1.4. Bargaining Power Of Suppliers
7.1.5. Threat Of Rivalry
7.2. Plasma Therapeutics Regulation
7.3. Market Trends
7.4. Regulatory Agencies
7.5. Clinical Guidelines
8. Geographical Analysis
8.1. North America
8.1.1. The United States
8.1.2. Canada
9. Company Profiles
9.1. Adma Biologics Inc.
9.1.1. Company Overview
9.1.2. Product Portfolio
9.1.3. Strategic Initiatives
9.2. Arthrex
9.2.1. Company Overview
9.2.2. Product Portfolio
9.2.3. Scot Analysis
9.2.4. Strategic Moves
9.3. Baxter International Inc.
9.3.1. Company Overview
9.3.2. Product Portfolio
9.3.3. Scot Analysis
9.4. Biotest Ag
9.4.1. Company Overview
9.4.2. Product Portfolio
9.4.3. Strategic Initiatives
9.5. Cerus Corp.
9.5.1. Company Overview
9.5.2. Product Portfolio
9.5.3. Strategic Initiatives
9.6. China Biologic Products Inc.
9.6.1. Company Overview
9.6.2. Product Portfolio
9.6.3. Strategic Initiatives
9.7. Csl Ltd.
9.7.1. Company Overview
9.7.2. Product Portfolio
9.7.3. Product Portfolio
9.8. General Electric Co.
9.8.1. Company Overview
9.8.2. Product Portfolio
9.8.3. Swot Analysis
9.8.4. Strategic Initiatives
9.9. Grifols International S.A.
9.9.1. Company Overview
9.9.2. Product Portfolio
9.9.3. Strategic Initiatives
9.10. Octopharma Ag
9.10.1. Company Overview
9.10.2. Product Portfolio
9.10.3. Strategic Initiatives
9.11. Shire Plc
9.11.1. Company Overview
9.11.2. Product Portfolio
9.11.3. Scot Analysis
9.11.4. Strategic Initiatives
Table List
Table 1 North America Blood Plasma Market 2018-2026 ($ Million)
Table 2 Blood Plasma Components
Table 3 North America Blood Plasma Market By Blood Type 2018-2026 ($ Million)
Table 4 North America Blood Plasma Market In Immunoglobulin 2018-2026 ($ Million)
Table 5 North America Blood Plasma Market In Immunoglobulin By Types 2018-2026 ($ Million)
Table 6 North America Immunoglobulin Market In Intravenous Immunoglobulin 2018-2026 ($ Million)
Table 7 North America Immunoglobulin Market In Subcutaneous Immunoglobulin 2018-2026 ($ Million)
Table 8 North America Immunoglobulin Market In Other Immunoglobulin Type 2018-2026 ($ Million)
Table 9 North America Blood Plasma Market In Albumin 2018-2026 ($ Million)
Table 10 North America Blood Plasma Market In Hyperimmunes 2018-2026 ($ Million)
Table 11 North America Blood Plasma Market In Coagulation Factor Concentrates 2018-2026 ($ Million)
Table 12 North America Blood Plasma Market In Other Plasma Fractionation Products 2018-2026 ($ Million)
Table 13 Protease Inhibitors Used In The Hiv Infection Treatment
Table 14 North America Blood Plasma Market By Application 2018-2026 ($ Million)
Table 15 North America Blood Plasma Market In Immunology 2018-2026 ($ Million)
Table 16 North America Blood Plasma Market In Oncology 2018-2026 ($ Million)
Table 17 North America Blood Plasma Market In Pulmonology 2018-2026 ($ Million)
Table 18 North America Blood Plasma Market In Rheumatology 2018-2026 ($ Million)
Table 19 North America Blood Plasma Market In Transplantation 2018-2026 ($ Million)
Table 20 North America Blood Plasma Market In Neurology 2018-2026 ($ Million)
Table 21 North America Blood Plasma Market In Hematology 2018-2026 ($ Million)
Table 22 North America Blood Plasma Market In Other Applications 2018-2026 ($ Million)
Table 23 North America Blood Plasma Market By End User 2018-2026 ($ Million)
Table 24 North America Blood Plasma Market In Hospitals And Clinics 2018-2026 ($ Million)
Table 25 North America Blood Plasma Market In Research Laboratories 2018-2026 ($ Million)
Table 26 North America Blood Plasma Market In Academic Institutions 2018-2026 ($ Million)
Table 27 North America Blood Plasma Market 2018-2026 ($ Million)
Figure List
Figure 1 North America Blood Plasma Market 2018-2026 ($ Million)
Figure 2 Immunoglobulin Infusions Side Effects
Figure 3 Role Of Fibrin Sealant In Coagulation Cascade
Figure 4 North America Blood Plasma Market In Immunoglobulin 2018-2026 ($ Million)
Figure 5 North America Blood Plasma Market In Albumin 2018-2026 ($ Million)
Figure 6 Hyperimmunes Isolation Process
Figure 7 North America Blood Plasma Market In Hyperimmunes 2018-2026 ($ Million)
Figure 8 North America Blood Plasma Market In Coagulation Factor Concentrates 2018-2026 ($ Million)
Figure 9 North America Blood Plasma Market In Other Plasma Fractionation Products 2018-2026 ($ Million)
Figure 10 North America Blood Plasma Market In Immunology 2018-2026 ($ Million)
Figure 11 North America Blood Plasma Market In Oncology 2018-2026 ($ Million)
Figure 12 North America Blood Plasma Market In Pulmonology 2018-2026 ($ Million)
Figure 13 Lupus Infection Symptoms
Figure 14 North America Blood Plasma Market In Rheumatology 2018-2026 ($ Million)
Figure 15 North America Blood Plasma Market In Transplantation 2018-2026 ($ Million)
Figure 16 North America Blood Plasma Market In Neurology 2018-2026 ($ Million)
Figure 17 North America Blood Plasma Market In Hematology 2018-2026 ($ Million)
Figure 18 North America Blood Plasma Market In Other Applications 2018-2026 ($ Million)
Figure 19 North America Blood Plasma Market In Hospitals And Clinics 2018-2026 ($ Million)
Figure 20 North America Blood Plasma Market In Research Laboratories 2018-2026 ($ Million)
Figure 21 North America Blood Plasma Market In Academic Institutions 2018-2026 ($ Million)
Figure 22 The United States Blood Plasma Market 2018-2026 ($ Million)
Figure 23 Canada Blood Plasma Market 2018-2026 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report